Australia's most trusted
source of pharma news
Wednesday, 26 June 2024
Posted 14 June 2024 PM
An Australian director who illegally supplied performance and image enhancing drugs has been given a suspended sentence, with the TGA warning it will crackdown on those that put profit ahead of safety.
At a Sydney court hearing, Ryan Gregory McTeigue was sentenced to two years imprisonment for his role in the unlawful manufacture, supply, advertising and export of SARMs, SERMs, and items listed in the Poisons Standard under Schedule 4 and Schedule 10.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.